EUVIMEDEUVIMED entdecken
Open Access

Plasma Ceramides and Sphingomyelins and Sudden Cardiac Death in the Cardiovascular Health Study

Lee B Bockus, Paul N Jensen, Amanda M Fretts, Andrew N Hoofnagle, Barbara McKnight, Colleen M Sitlani, David S Siscovick, Irena B King, Bruce M Psaty, Nona Sotoodehnia, Rozenn N Lemaitre

JAMA Network Open · 17.11.2023 · 6 (11) · e2343854

DOI: 10.1001/jamanetworkopen.2023.43854 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 17.11.2023. Verfasst von Lee B Bockus und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Washington, Seattle. Hauptthemen laut MEDLINE: Sphingomyelins, Ceramides. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Sphingolipids, including ceramides and sphingomyelins, may influence the pathophysiology and risk of sudden cardiac death (SCD) through multiple biological activities. Whether the length of the fatty acid acylated to plasma sphingolipid species is associated with SCD risk is not known.

Objective

To determine whether the saturated fatty acid length of plasma ceramides and sphingomyelins influences the association with SCD risk. Design, Setting, and Participants In this cohort study, multivariable Cox proportional hazards regression models were used to examine the association of sphingolipid species with SCD risk. The study population included 4612 participants in the Cardiovascular Health Study followed up prospectively for a median of 10.2 (IQR, 5.5-11.6) years. Baseline data were collected from January 1992 to December 1995 during annual examinations. Data were analyzed from February 11, 2020, to September 9, 2023. Exposures Eight plasma sphingolipid species (4 ceramides and 4 sphingomyelins) with saturated fatty acids of 16, 20, 22, and 24 carbons. Main Outcome and Measure Association of plasma ceramides and sphingomyelins with saturated fatty acids of different lengths with SCD risk.

Results

Among the 4612 CHS participants included in the analysis (mean [SD] age, 77 [5] years; 2724 [59.1%] women; 6 [0.1%] American Indian; 4 [0.1%] Asian; 718 [15.6%] Black; 3869 [83.9%] White, and 15 [0.3%] Other), 215 SCD cases were identified. In adjusted Cox proportional hazards regression analyses, plasma ceramides and sphingomyelins with palmitic acid (Cer-16 and SM-16) were associated with higher SCD risk per higher SD of log sphingolipid levels (hazard ratio [HR] for Cer-16, 1.34 [95% CI, 1.12-1.59]; HR for SM-16, 1.37 [95% CI, 1.12-1.67]). Associations did not differ by baseline age, sex, race, or body mass index. No significant association of SCD with sphingolipids with very-long-chain saturated fatty acids was observed after correction for multiple testing (HR for ceramide with arachidic acid, 1.06 [95% CI, 0.90-1.24]; HR for ceramide with behenic acid, 0.92 [95% CI, 0.77-1.10]; HR for ceramide with lignoceric acid, 0.92 [95% CI, 0.77-1.09]; HR for sphingomyelin with arachidic acid, 0.83 [95% CI, 0.71-0.98]; HR for sphingomyelin with behenic acid, 0.84 [95% CI, 0.70-1.00]; HR for sphingomyelin with lignoceric acid, 0.86 [95% CI, 0.72-1.03]). Conclusions and Relevance The findings of this large, population-based cohort study of SCD identified that higher plasma levels of Cer-16 and SM-16 were associated with higher risk of SCD. Future studies are needed to examine the underlying mechanism of these associations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SphingomyelinsCeramidesHumansFemaleAgedMaleEicosanoic AcidsCohort StudiesFatty AcidsSphingolipidsDeath, Sudden, Cardiac

Substanzen

SphingomyelinsCeramidesEicosanoic AcidsFatty AcidsSphingolipids

Autor:innen und Institutionen

  • Department of Medicine, University of Washington, Seattle.
  • Department of Epidemiology, University of Washington, Seattle.
  • Departments of Laboratory Medicine and Pathology, University of Washington, Seattle.
  • Department of Biostatistics, University of Washington, Seattle.
  • New York Academy of Medicine, New York.
  • Department of Internal Medicine, University of New Mexico, Albuquerque.

Förderung

  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • NIA NIH HHS

Zitieren

APA

Bockus, L. B., Jensen, P. N., Fretts, A. M., Hoofnagle, A. N., McKnight, B., Sitlani, C. M., Siscovick, D. S., King, I. B., Psaty, B. M., Sotoodehnia, N., & Lemaitre, R. N. (2023). Plasma Ceramides and Sphingomyelins and Sudden Cardiac Death in the Cardiovascular Health Study. JAMA Network Open, 6(11), e2343854. https://doi.org/10.1001/jamanetworkopen.2023.43854

Vancouver

Bockus LB, Jensen PN, Fretts AM, Hoofnagle AN, McKnight B, Sitlani CM, et al. Plasma Ceramides and Sphingomyelins and Sudden Cardiac Death in the Cardiovascular Health Study. JAMA Network Open. 2023;6(11):e2343854. doi:10.1001/jamanetworkopen.2023.43854

BibTeX
@article{Bockus2023,
  author = {Bockus, Lee B and Jensen, Paul N and Fretts, Amanda M and Hoofnagle, Andrew N and McKnight, Barbara and Sitlani, Colleen M and Siscovick, David S and King, Irena B and Psaty, Bruce M and Sotoodehnia, Nona and Lemaitre, Rozenn N},
  title = {Plasma Ceramides and Sphingomyelins and Sudden Cardiac Death in the Cardiovascular Health Study},
  journal = {JAMA Network Open},
  year = {2023},
  volume = {6},
  number = {11},
  pages = {e2343854},
  doi = {10.1001/jamanetworkopen.2023.43854}
}
Kostenlos starten →